Real-World Experience of Upadacitinib Dosing Reduction in Patients With Moderate Atopic Dermatitis: A Case Series Study in Taiwan. (2024). Dermatology Practical & Conceptual, 14(3), e2024186. https://doi.org/10.5826/dpc.1403a186